Travis Mickle
92Patents
21h-index
21Co-inventors
88Inventor score
Filing activity: May 29, 2002 → Apr 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7105486B2 | Abuse-resistant amphetamine compounds | Human Necessities | 83 | Expired |
| US7060708B2 | Active agent delivery systems and methods for protecting and administering active agents | Human Necessities | 76 | Expired |
| US7375083B2 | Pharmaceutical compositions for prevention of overdose or abuse | Human Necessities | 64 | Expired |
| US7678770B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 55 | Active |
| US7671030B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 54 | Active |
| US7223735B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 48 | Expired |
| US7655630B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 45 | Active |
| US7662787B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 43 | Active |
| US7659253B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 42 | Active |
| US7700561B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 40 | Active |
| US7674774B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7723305B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7687466B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7718619B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7678771B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7671031B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7659254B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 38 | Active |
| US7375082B2 | Abuse-resistant hydrocodone compounds | Human Necessities | 32 | Expired |
| US8101661B2 | Polar hydrophilic prodrugs and non-standard amino acid conjugates of amphetamine and other stimulants and processes for making and using the same | Human Necessities | 27 | Active |
| US8461137B2 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | Human Necessities | 25 | Active |
| US7687467B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 25 | Active |
| US7427600B2 | Active agent delivery systems and methods for protecting and administering active agents | Human Necessities | 21 | Expired |
| US8759368B2 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | Human Necessities | 18 | Active |
| US7776917B2 | Non-standard amino acid conjugates of amphetamine and processes for making and using the same | Human Necessities | 18 | Active |
| US8748413B2 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | Human Necessities | 17 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.